The invention concerns substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one, more particularly for therapeutic purposes, pharmaceutical means and the use thereof in treatment, in particular for prophylaxis and for the treatment of tumorous diseases.